As Head of Disease Discovery at Sema4, Lauren Peters, Ph.D. is designing next generation in silico models of disease to uncover patient data driven mechanisms of disease pathogenesis and identification of novel patient subsets, biomarkers and approaches to therapeutic discovery. Dr. Peters is also an Assistant Professor in the Department of Genetics & Genomic Sciences and the Icahn Institute for Data Science & Genomic Technology at the Icahn School of Medicine at Mount Sinai where she has focused on the analysis and experimental validation of computational models of disease in collaboration with Janssen and led numerous publications including in Nature Genetics, Gastroenterology and Nature Immunology. Prior to completing her Ph.D. in Biomedical Science at the Icahn School of Medicine at Mount Sinai in Immunology and Genetics, Dr. Peters was a scientist in oncology therapeutic discovery in the Cell Biology group in R&D at Imclone Systems, Eli Lilly, worked in business development at Regeneron and in Genetics and Development at Columbia University, where she earned a M.A. in Biotechnology. Dr. Peters also has worked in Information Technology at Barclays and management consulting at Kaiser Associates; advising Fortune 100 clients in the pharmaceutical, technology and other industries on business strategy. She holds a BA in International Relations with a concentration in Economics from Boston University.